Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immune Tolerance Induction for Treating Inhibitors in People With Congenital Haemophilia a or B." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review. Accessed 29 March 2024.
Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review. Accessed March 29, 2024.
Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review
Immune Tolerance Induction for Treating Inhibitors in People With Congenital Haemophilia a or B [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B
ID - 438410
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -